kairoby Opportune Labs

HCG

Human chorionic gonadotropin acts on reproductive hormone pathways and has specific fertility and endocrine uses. Its established medical roles should be separated from unsupported weight-loss and broad hormone-optimization claims.

Prescription medicineApproved clinical uses in selected reproductive disorders; no established obesity-treatment benefit.
Kairo editorial · Sources reviewed September 9, 20264 sources
On this page
  1. Overview
  2. What the evidence shows
  3. Safety
  4. Common questions
  5. Questions for your clinician
  6. Sources

Overview

Product & regulatory status

FDA-approved injectable prescription products exist. HCG is not approved for weight loss or over-the-counter use.

LH-like activity

HCG has luteinizing-hormone-like action, stimulating gonadal steroid production and reproductive processes when the relevant tissues can respond. [1]

What the evidence shows

The diagnosis matters

Pregnyl is indicated for selected male hypogonadotropic hypogonadism and for ovulation induction in appropriately selected infertile women after gonadotropin treatment. It is not a general treatment for every cause of infertility or low testosterone. [1]

Weight-loss claims are unsupported

FDA states there is no substantial evidence that HCG adds weight loss beyond calorie restriction, redistributes body fat or reduces hunger on restrictive diets. A scale change during such a diet does not establish an HCG effect. [2]

What remains unknown

A testosterone increase does not by itself establish sperm recovery, pregnancy or live birth. Each is a separate outcome that depends on the underlying reproductive condition.

Safety

Fertility-treatment risks

Ovarian hyperstimulation, multiple pregnancy and thromboembolic complications can occur in relevant fertility-treatment settings. These require specialist selection and monitoring. [1]

Systemic adverse effects

Hypersensitivity, fluid retention and gynecomastia are among labeled concerns; the risks depend on the patient and the treatment context. [1]

Product distinction

Prescription injections and products marketed as homeopathic drops or sprays are not equivalent. FDA has not approved HCG weight-loss products. [2]

Understanding product quality

Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]

When to seek urgent help

Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]

A starting point for discussion

This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.

Common questions

Is HCG a fat-loss drug?

No. Its approved reproductive indications do not validate HCG diet or metabolism-reset claims.

What should fertility follow-up measure?

Discuss the outcome appropriate to the diagnosis rather than treating a serum testosterone value as proof of fertility.

Questions for your clinician

Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?

Sources

  1. Pregnyl prescribing informationUS hCG product label; selected reproductive indications, mechanism, ovarian and systemic risks.
  2. FDA: HCG products and weight-loss claimsFDA differentiates approved reproductive indications from unsupported obesity and homeopathic-product claims.
  3. Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
  4. AnaphylaxisMedlinePlus · recognizing an emergency

Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.